Annual Shareholders Equity
$1.10 B
-$639.13 M-36.81%
December 31, 2023
Summary
- As of February 8, 2025, DNA annual stockholders equity is $1.10 billion, with the most recent change of -$639.13 million (-36.81%) on December 31, 2023.
- During the last 3 years, DNA annual shareholders equity has risen by +$635.78 million (+137.80%).
- DNA annual shareholders equity is now -36.81% below its all-time high of $1.74 billion, reached on December 31, 2022.
Performance
DNA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$797.94 M
-$35.13 M-4.22%
September 30, 2024
Summary
- As of February 8, 2025, DNA quarterly stockholders equity is $797.94 million, with the most recent change of -$35.13 million (-4.22%) on September 30, 2024.
- Over the past year, DNA quarterly shareholders equity has dropped by -$299.21 million (-27.27%).
- DNA quarterly shareholders equity is now -54.04% below its all-time high of $1.74 billion, reached on December 31, 2022.
Performance
DNA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
DNA Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.8% | -27.3% |
| 3 y3 years | +137.8% | -27.3% |
| 5 y5 years | - | - |
DNA Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.8% | at low | -54.0% | at low |
| 5 y | 5-year | -36.8% | +137.8% | -54.0% | +73.0% |
| alltime | all time | -36.8% | +137.8% | -54.0% | +73.0% |
Ginkgo Bioworks Holdings Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $797.94 M(-4.2%) |
| Jun 2024 | - | $833.07 M(-15.6%) |
| Mar 2024 | - | $987.27 M(-10.0%) |
| Dec 2023 | $1.10 B(-36.8%) | $1.10 B(-12.4%) |
| Sep 2023 | - | $1.25 B(-16.7%) |
| Jun 2023 | - | $1.50 B(-6.5%) |
| Mar 2023 | - | $1.61 B(-7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $1.74 B(+15.3%) | $1.74 B(+21.0%) |
| Sep 2022 | - | $1.43 B(-6.6%) |
| Jun 2022 | - | $1.54 B(-2.9%) |
| Mar 2022 | - | $1.58 B(+5.0%) |
| Dec 2021 | $1.51 B(+226.3%) | $1.51 B(-3.0%) |
| Sep 2021 | - | $1.55 B(+236.3%) |
| Dec 2020 | $461.38 M | $461.38 M |
FAQ
- What is Ginkgo Bioworks Holdings annual stockholders equity?
- What is the all time high annual shareholders equity for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual shareholders equity year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly shareholders equity year-on-year change?
What is Ginkgo Bioworks Holdings annual stockholders equity?
The current annual shareholders equity of DNA is $1.10 B
What is the all time high annual shareholders equity for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual stockholders equity is $1.74 B
What is Ginkgo Bioworks Holdings annual shareholders equity year-on-year change?
Over the past year, DNA annual stockholders equity has changed by -$639.13 M (-36.81%)
What is Ginkgo Bioworks Holdings quarterly stockholders equity?
The current quarterly shareholders equity of DNA is $797.94 M
What is the all time high quarterly shareholders equity for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly stockholders equity is $1.74 B
What is Ginkgo Bioworks Holdings quarterly shareholders equity year-on-year change?
Over the past year, DNA quarterly stockholders equity has changed by -$299.21 M (-27.27%)